Advertisement
Advertisement

ASMB

ASMB logo

Assembly Biosciences, Inc

25.77
USD
Sponsored
+0.06
+0.25%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

25.80

+0.03
+0.12%

ASMB Earnings Reports

Positive Surprise Ratio

ASMB beat 25 of 37 last estimates.

68%

Next Report

Date of Next Report
Mar 18, 2026
Estimate for Q4 25 (Revenue/ EPS)
$7.57M
/
-$0.66
Implied change from Q3 25 (Revenue/ EPS)
-29.82%
/
-8.33%
Implied change from Q4 24 (Revenue/ EPS)
+2.91%
/
-57.96%

Assembly Biosciences, Inc earnings per share and revenue

On Nov 10, 2025, ASMB reported earnings of -0.72 USD per share (EPS) for Q3 25, beating the estimate of -0.79 USD, resulting in a 8.88% surprise. Revenue reached 10.79 million, compared to an expected 7.61 million, with a 41.80% difference. The market reacted with a +3.31% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.66 USD, with revenue projected to reach 7.57 million USD, implying an decrease of -8.33% EPS, and decrease of -29.82% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Teva Pharmaceutical Industries Limited - ADR
Report Date
Jan 28, 2026 For Q4 25
Estimate
$0.69
Actual
$0.96
Surprise
+38.55%
logo
Dr. Reddy's Laboratories Limited - ADR
Report Date
Jan 21, 2026 For Q3 26
Estimate
$13.86
Actual
$14.65
Surprise
+5.66%
FAQ
For Q3 2025, Assembly Biosciences, Inc reported EPS of -$0.72, beating estimates by 8.88%, and revenue of $10.79M, 41.8% above expectations.
The stock price moved up 3.31%, changed from $32.07 before the earnings release to $33.13 the day after.
The next earning report is scheduled for Mar 18, 2026.
Based on 6 analysts, Assembly Biosciences, Inc is expected to report EPS of -$0.66 and revenue of $7.57M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement